Joli D. Fermo

438 total citations
17 papers, 321 citations indexed

About

Joli D. Fermo is a scholar working on Geriatrics and Gerontology, Toxicology and Pharmacology. According to data from OpenAlex, Joli D. Fermo has authored 17 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Geriatrics and Gerontology, 4 papers in Toxicology and 3 papers in Pharmacology. Recurrent topics in Joli D. Fermo's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers) and Medication Adherence and Compliance (3 papers). Joli D. Fermo is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers) and Medication Adherence and Compliance (3 papers). Joli D. Fermo collaborates with scholars based in United States and Saudi Arabia. Joli D. Fermo's co-authors include Elinor C. Chumney, Kelly R. Ragucci, John S. Markowitz, Andrea M. Wessell, Heather P. Whitley, Gary M. Oderda, Eun‐So Lee, Laura Shane‐McWhorter, Walter A. Brzezinski and Eric M. Matheson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Joli D. Fermo

15 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joli D. Fermo United States 9 100 79 53 44 40 17 321
Arsène Zongo Canada 10 95 0.9× 64 0.8× 41 0.8× 56 1.3× 59 1.5× 37 293
M Kriska Slovakia 13 33 0.3× 34 0.4× 25 0.5× 35 0.8× 72 1.8× 59 511
J. Chris Bradberry United States 12 55 0.6× 77 1.0× 13 0.2× 25 0.6× 25 0.6× 20 382
Tomasz Zaprutko Poland 11 24 0.2× 42 0.5× 33 0.6× 14 0.3× 28 0.7× 49 364
P. Poon Hong Kong 12 22 0.2× 29 0.4× 37 0.7× 31 0.7× 26 0.7× 28 469
Helen Berlie United States 11 220 2.2× 63 0.8× 19 0.4× 48 1.1× 53 1.3× 25 551
Joyce A. Generali United States 10 21 0.2× 87 1.1× 40 0.8× 17 0.4× 36 0.9× 85 375
James F. Burris United States 16 138 1.4× 54 0.7× 61 1.2× 12 0.3× 79 2.0× 61 710
Danielle R. Fixen United States 10 13 0.1× 83 1.1× 33 0.6× 58 1.3× 83 2.1× 26 412
Marzena Chrostowska Poland 10 54 0.5× 30 0.4× 25 0.5× 43 1.0× 14 0.3× 33 433

Countries citing papers authored by Joli D. Fermo

Since Specialization
Citations

This map shows the geographic impact of Joli D. Fermo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joli D. Fermo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joli D. Fermo more than expected).

Fields of papers citing papers by Joli D. Fermo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joli D. Fermo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joli D. Fermo. The network helps show where Joli D. Fermo may publish in the future.

Co-authorship network of co-authors of Joli D. Fermo

This figure shows the co-authorship network connecting the top 25 collaborators of Joli D. Fermo. A scholar is included among the top collaborators of Joli D. Fermo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joli D. Fermo. Joli D. Fermo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mazur, Joseph, et al.. (2025). 195 Evaluation of Various Treatment Strategies for Acquired Hemophilia A. Research and Practice in Thrombosis and Haemostasis. 9. 102812–102812.
2.
Smith, Melissa J., et al.. (2024). Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity. Journal of Thrombosis and Thrombolysis. 57(4). 603–612. 1 indexed citations
3.
Fermo, Joli D., et al.. (2023). Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin. Journal of Primary Care & Community Health. 14. 4277817748–4277817748.
4.
Matheson, Eric M., et al.. (2023). Temporomandibular Disorders: Rapid Evidence Review.. PubMed. 107(1). 52–58. 22 indexed citations
5.
Fermo, Joli D., et al.. (2013). Elevated international normalized ratio with the consumption of grapefruit and use of warfarin. SHILAP Revista de lepidopterología. 1. 2050313X13511602–2050313X13511602. 2 indexed citations
6.
Ragucci, Kelly R., et al.. (2009). Evaluation of patient perceptions and outcomes related to anticoagulation point-of-care testing in ambulatory care clinics. Pharmacy Practice. 7(4). 213–7. 6 indexed citations
7.
Herndon, Christopher M., et al.. (2008). Management of Chronic Nonmalignant Pain with Nonsteroidal Antiinflammatory Drugs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(6). 788–805. 24 indexed citations
8.
Whitley, Heather P., Joli D. Fermo, Elinor C. Chumney, & Walter A. Brzezinski. (2007). Effect of patient-specific factors on weekly warfarin dose.. PubMed Central. 26 indexed citations
9.
Whitley, Heather P., Joli D. Fermo, & Elinor C. Chumney. (2006). 5‐Year Evaluation of Electronic Medical Record Flag Alerts for Patients Warranting Secondary Prevention of Coronary Heart Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(5). 682–688. 4 indexed citations
10.
Lee, Eun‐So & Joli D. Fermo. (2006). Warfarin and Royal Jelly Interaction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(4). 583–586. 16 indexed citations
11.
Whitley, Heather P., Joli D. Fermo, Kelly R. Ragucci, & Elinor C. Chumney. (2006). Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharmacy Practice. 4(4). 183–183. 25 indexed citations
12.
Ragucci, Kelly R., et al.. (2005). Objective structured clinical examinations for an ambulatory care pharmacy rotation. American Journal of Health-System Pharmacy. 62(9). 927–929. 5 indexed citations
13.
Ragucci, Kelly R., Joli D. Fermo, Andrea M. Wessell, & Elinor C. Chumney. (2005). Effectiveness of Pharmacist‐Administered Diabetes Mellitus Education and Management Services. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(12). 1809–1816. 72 indexed citations
14.
Shrader, Sarah, et al.. (2004). Azithromycin and Warfarin Interaction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(7). 945–949. 8 indexed citations
15.
Fermo, Joli D., et al.. (2004). Atomoxetine, a Novel Treatment for Attention‐Deficit—Hyperactivity Disorder. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(8). 1020–1036. 74 indexed citations
16.
Blair, Melissa, et al.. (2003). Assessment of Web-Based Applications for Ambulatory Care Rotations. Annals of Pharmacotherapy. 37(12). 1785–1788. 5 indexed citations
17.
Shane‐McWhorter, Laura, et al.. (2002). National Survey of Pharmacist Certified Diabetes Educators. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(12). 1579–1593. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arsène Zongo Breakdown of academic impact, for papers by M Kriska Breakdown of academic impact, for papers by J. Chris Bradberry Breakdown of academic impact, for papers by Tomasz Zaprutko Breakdown of academic impact, for papers by P. Poon Breakdown of academic impact, for papers by Helen Berlie Breakdown of academic impact, for papers by Joyce A. Generali Breakdown of academic impact, for papers by James F. Burris Breakdown of academic impact, for papers by Danielle R. Fixen Breakdown of academic impact, for papers by Marzena Chrostowska
Rankless by CCL
2026